generation,stage,candidate_idx,risk_aversion,herd_behavior,profit_driven,ticker,company,id,quarter,date,permno,holding_t,y_true,pred,abs_error,reward,valid,best_k,profile_strength_mode,x_risk_mean,x_herd_mean,x_profit_mean,overall_mean,raw_output,reason,answer_body
44,population,0,0.3999996000004001,0.19999980000020004,0.3999996000004001,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the fund's growth orientation and capture potential upside.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the fund's growth orientation and capture potential upside.","{""holding_log_delta"": -0.03}"
44,population,1,0.2999997000003,0.49999950000050003,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.","{""holding_log_delta"": -0.03}"
44,population,2,0.2999997000003,0.49999950000050003,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.","{""holding_log_delta"": -0.03}"
44,population,3,0.2999997000003,0.44999955000045005,0.24999975000025002,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound with positive growth signals. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting room for increased allocation to align with the positive fundamentals and benchmark importance. Considering the low stock volatility (0.17) and moderate trading volume, the fund might increase its position modestly to capture growth opportunities without significant risk exposure.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound with positive growth signals. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting room for increased allocation to align with the positive fundamentals and benchmark importance. Considering the low stock volatility (0.17) and moderate trading volume, the fund might increase its position modestly to capture growth opportunities without significant risk exposure.","{""holding_log_delta"": -0.03}"
44,population,4,0.34999965000035,0.14999985000015,0.49999950000050003,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. However, the stock's previous quarter volatility (0.170) is above average, which might temper the magnitude of any increase due to risk considerations.","{""holding_log_delta"": -0.03}"
44,population,5,0.2999997000003,0.2999997000003,0.3999996000004001,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. Considering the low stock volatility (0.17) and moderate trading volume, the fund might increase the position modestly without significant risk exposure.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. Considering the low stock volatility (0.17) and moderate trading volume, the fund might increase the position modestly without significant risk exposure.","{""holding_log_delta"": -0.03}"
44,population,6,0.49999950000050003,0.2999997000003,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.","{""holding_log_delta"": -0.03}"
44,population,7,0.34999965000035,0.44999955000045005,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound with positive growth signals. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting room for increase. Considering the positive fundamentals and the fund's active growth orientation, a modest increase in holding is expected, though limited by the stock's already elevated volatility.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound with positive growth signals. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting room for increase. Considering the positive fundamentals and the fund's active growth orientation, a modest increase in holding is expected, though limited by the stock's already elevated volatility.","{""holding_log_delta"": -0.03}"
44,population,8,0.5499994500005501,0.24999975000025002,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.","{""holding_log_delta"": -0.03}"
44,population,9,0.3999996000004001,0.09999990000010002,0.49999950000050003,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the fund's growth orientation and capture potential upside.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and strong asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally sound. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the fund's growth orientation and capture potential upside.","{""holding_log_delta"": -0.03}"
44,population,10,0.34999965000035,0.19999980000020004,0.44999955000045005,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.03,0.12144298390252455,-0.12144298390252455,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.</think>
<answer>
{""holding_log_delta"": -0.03}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM, and the stock's low S&P 500 weight suggests limited benchmark pressure. With positive fundamentals and manageable risk, a modest increase in holding might be expected to align with the stock's growth potential.","{""holding_log_delta"": -0.03}"
44,population,11,0.44999955000045005,0.34999965000035,0.19999980000020004,TECH,BIO TECHNE CORP,466,NA,2019-07-01 00:00:00,75694,589.156103,0.09144298390252455,-0.01,0.10144298390252454,-0.10144298390252454,True,1,type_mean,0.0083004769074155,0.0070097321687576,0.0811969348655934,0.03216904798058883,"
<think>Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. Considering the low stock volatility (0.17) and moderate trading volume, the expected increase in holding should be modest but positive.</think>
<answer>
{""holding_log_delta"": -0.01}
</answer>","Given the firm's high profitability (profit=0.166) and positive asset growth (Gat=0.146), alongside its moderate beta (1.17) indicating average market risk, the stock appears fundamentally strong. The fund's current holding is relatively small compared to its AUM and the stock's S&P 500 weight, suggesting potential for increased allocation to align with the benchmark and capitalize on the positive fundamentals. Considering the low stock volatility (0.17) and moderate trading volume, the expected increase in holding should be modest but positive.","{""holding_log_delta"": -0.01}"
